Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
0
EDQM
0
USP
0
JP
0
Others
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
Finished Drug Prices
NA
1. (5s,8s)-8-(((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4.5)decan-2-one
2. 8-((1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4,5)decan-2-one
3. Rolapitant
4. Sch 619734
5. Varubi
1. Rolapitant Hydrochloride Hydrate
2. 914462-92-3
3. Rolapitant Hcl
4. Varubi
5. Sch619734
6. Rolapitant Hcl H20
7. Rolapitant Hydrochloride [usan]
8. Rolapitant Hydrochloride Monohydrate
9. 57o5s1qsaq
10. Varubi (tn)
11. (5s,8s)-8-(((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-1,7-diazaspiro(4.5)decan-2-one Monohydrochloride Monohydrate
12. (5s,8s)-8-[[(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]methyl]-8-phenyl-1,9-diazaspiro[4.5]decan-2-one;hydrate;hydrochloride
13. Rolapitant Hydrochloride (usan)
14. Rolapitant Hcl Hydrate
15. 1,7-diazaspiro(4.5)decan-2-one, 8-(((1r)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)methyl)-8-phenyl-, Monohydrochloride, Monohydrate, (5s,8s)-
16. Unii-57o5s1qsaq
17. Rolapitant.hcl.h2o
18. Schembl2173125
19. Chembl3707330
20. Chebi:90911
21. Dtxsid70238570
22. Bcp15968
23. Mfcd19443696
24. Rolapitant Hydrochloride [mi]
25. Rolapitant Monohydrochloride Monohydrate
26. Ac-35397
27. Bs-17849
28. Rolapitant Hydrochloride [orange Book]
29. D08988
30. D83025
31. Rolapitant Hydrochloride Monohydrate [who-dd]
32. Q27162902
33. (5s,8s)-8-({(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-2-oxo-8-phenyl-1,7-diazaspiro[4.5]decan-7-ium Chloride--water (1/1)
34. (5s,8s)-8-({(1r)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}methyl)-8-phenyl-1,7-diazaspiro[4.5]decan-2-one Hydrochloride--water (1/1)
Molecular Weight | 555.0 g/mol |
---|---|
Molecular Formula | C25H29ClF6N2O3 |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 5 |
Exact Mass | 554.1770895 g/mol |
Monoisotopic Mass | 554.1770895 g/mol |
Topological Polar Surface Area | 51.4 Ų |
Heavy Atom Count | 37 |
Formal Charge | 0 |
Complexity | 731 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 3 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Neurokinin-1 Receptor Antagonists
Compounds that inhibit or block the activity of NEUROKININ-1 RECEPTORS. (See all compounds classified as Neurokinin-1 Receptor Antagonists.)
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
ABOUT THIS PAGE
A Rolapitant HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Rolapitant HCl, including repackagers and relabelers. The FDA regulates Rolapitant HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Rolapitant HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Rolapitant HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Rolapitant HCl supplier is an individual or a company that provides Rolapitant HCl active pharmaceutical ingredient (API) or Rolapitant HCl finished formulations upon request. The Rolapitant HCl suppliers may include Rolapitant HCl API manufacturers, exporters, distributors and traders.
click here to find a list of Rolapitant HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Rolapitant HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Rolapitant HCl active pharmaceutical ingredient (API) in detail. Different forms of Rolapitant HCl DMFs exist exist since differing nations have different regulations, such as Rolapitant HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Rolapitant HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Rolapitant HCl USDMF includes data on Rolapitant HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Rolapitant HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Rolapitant HCl suppliers with USDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Rolapitant HCl as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Rolapitant HCl API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Rolapitant HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Rolapitant HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Rolapitant HCl NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Rolapitant HCl suppliers with NDC on PharmaCompass.
Rolapitant HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Rolapitant HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Rolapitant HCl GMP manufacturer or Rolapitant HCl GMP API supplier for your needs.
A Rolapitant HCl CoA (Certificate of Analysis) is a formal document that attests to Rolapitant HCl's compliance with Rolapitant HCl specifications and serves as a tool for batch-level quality control.
Rolapitant HCl CoA mostly includes findings from lab analyses of a specific batch. For each Rolapitant HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Rolapitant HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Rolapitant HCl EP), Rolapitant HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Rolapitant HCl USP).
LOOKING FOR A SUPPLIER?